AI-based Medical Imaging Market: Revolutionizing Diagnostics with Advanced Technology

The AI-based medical imaging market is transforming healthcare diagnostics with smarter, faster, and more accurate imaging solutions. Valued at USD 3,276.29 Million in 2024, the market is projected to grow from USD 4,772.9 Million in 2025 to a staggering USD 96,823.74 Million by 2033, registering a remarkable CAGR of 45.68%. This surge is fueled by the increasing adoption of AI technologies in medical imaging specialties and modalities, helping radiologists enhance image quality, accuracy, and workflow efficiency.

Download Sample

AI-based Medical Imaging: An Overview
AI-based medical imaging leverages artificial intelligence to detect abnormalities by analyzing imaging intensities and patterns. Available as software tools or platforms, these solutions speed up disease screening, improve image clarity, and optimize radiologists’ productivity. Traditional imaging techniques often struggle to detect real-time changes, whereas AI can efficiently monitor conditions like brain tumors and cancers, enabling precise treatment decisions.

Growth Factors Driving the Market

• Rise in Approved AI-based Platforms: FDA approvals for AI-based imaging diagnostics have accelerated, with at least 16 applications cleared for clinical use. Companies like Zebra Medical Vision and Canon Medical Systems have received approvals for advanced imaging products, paving the way for market growth.

• Increasing Diagnostic Procedures: Rising demand for imaging services, particularly for cancer, cardiac, and respiratory conditions, is driving adoption. Over 90% of healthcare data comes from medical images, but more than 97% remains unanalyzed, highlighting the need for AI integration.

Challenges Restricting Market Growth

• Lower Adoption in LMICs: Many low- and middle-income countries lack the digital infrastructure and skilled radiologists to implement AI-based imaging. For example, Tanzania has only 60 radiologists for 58 million people, highlighting the gap.

Market Opportunities

• Growing Adoption in Developed Countries: Developed regions like North America and Europe are rapidly adopting AI-based imaging, thanks to regulatory approvals, reimbursements, and rising radiologist workloads. In the US, approximately 250,000 radiologists handle diagnostic imaging, and the workforce is expected to grow 7% from 2019 to 2029, further boosting AI adoption.

Regional Insights

• North America: Dominates the market with a CAGR of 45.12%, driven by high investments, collaborations, and reimbursement policies. For instance, Viz.ai’s Viz LVO received Medicare NTAP reimbursement.

• Europe: Expected CAGR of 43.93%, with collaborative research between companies, hospitals, and governments driving AI innovation.

• Asia-Pacific: Emerging adoption with China and Japan leading the region. Government investments and collaborations indicate exponential growth potential, despite high adoption costs.

• Latin America: Opportunities arise from rising healthcare expenditure, growing diagnostic service providers, and research collaborations, such as IBM’s AI Horizons Network in Brazil.

• Middle East & Africa: Countries like Turkey, Saudi Arabia, South Africa, and UAE are increasing AI adoption due to rising chronic diseases and the need to manage healthcare costs efficiently.

Technology Insights

• Deep Learning: The leading technology segment with a projected CAGR of 47.04%, capable of detecting abnormalities and classifying diseases through multiple layers of neural network processing.

Application Insights

• Neurology: Largest revenue contributor, expected CAGR of 46.45%, with AI applied in molecular imaging of the central nervous system. Tools like Arterys Neuro AI achieve >95% accuracy in distinguishing tumors non-invasively.

Modalities Insights

• CT Imaging: Dominates the market with a CAGR of 46.16%, offering rapid and precise diagnostics while managing radiation exposure effectively.

End-User Insights

• Hospitals: Hold the highest market share, CAGR of 44.83%, driven by increased chronic disease prevalence and the surge in imaging activities post-COVID-19.

Key Players in AI-based Medical Imaging Market

• General Electric

• Siemens Healthineers

• Koninklijke Philips

• IBM Watson Health

• EchoNous

• Agfa-Gevaert Group/Agfa HealthCare

• Arterys

• Butterfly Network

• Caption Health

• CellmatiQ

• dentalXrai

• Avicenna.AI

Recent Developments

• May 2023: GE HealthCare obtained US FDA 510(k) certification for Precision DL, a deep learning-based image processing software.

• April 2023: Vuno secured a US patent for AI-based medical image analysis technology.

About Us:
Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.

Contact Us:
Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Website: https://straitsresearch.com/